Hikma Pharmaceuticals PLC Annual report 2010 notes to tHe ConsoLIdAted FInAnCIALstAtements Continued 8. otHer oPerAtInG exPenses net For the years ended 31 december 2010 2009 $000 $000 other operating expense 23,741 18,583 other operating income 16,528 3,054 7,213 15,529 Other operating expenses consist mainly of provisions against slow moving inventory items, abnormal spoilage, and foreign exchange losses.
Otheroperating income consists mainly of gains on revaluation of previously held equity interests of USD 7,176,000 see Note 39, gain on sale of intangible assets, other product related income, and other income.
FInAnCe InCome For the years ended 31 december 2010 2009 $000 $000 Interest income 346 514 10.
FInAnCe exPense For the years ended 31 december 2010 2009 $000 $000 Interest on bank overdrafts and loans 5,755 7,367 Interest on obligations under finance leases 206 197 other bank charges 7,895 5,263 13,856 12,827 11. tAx For the years ended 31 december 2010 2009 $000 $000 Current tax: uk current tax 560 double tax relief 560 Foreign tax 27,037 19,988 Prior year adjustments 691 1,035 deferred tax note 17 4,891 5,554 21,455 15,469 UK corporation tax is calculated at 28% 2009: 28% of the estimated assessable profit made in the UK for the year.
Effective tax rate for the Group is 17.74% 2009: 16.32%.
Taxation for other jurisdictions is calculated at the rates prevailing in the respective jurisdiction.
